halothane has been researched along with isradipine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Blanck, TJ; Drenger, B; Heitmiller, ES; Quigg, M | 1 |
| Böhm, M; Böhm, S; Erdmann, E; Kreuzer, E; Meyer, L; Reichart, B; Schmidt, U; Schwinger, RH; Uberfuhr, P | 1 |
| Blanck, TJ; Hollmann, C; Lee, DL; Yasukochi, S; Zhang, J | 1 |
| Drenger, B; Ginosar, Y; Gozal, Y | 1 |
| Blanck, TJ; Lee, DL; Zhang, J | 1 |
| Chandra, M; Drenger, B; Ginosar, Y; Gozal, Y; Reches, A | 1 |
| Louis, CF; Mickelson, JR; Roghair, T | 1 |
| de Lange, S; Lawrence, CJ; Prinzen, FW; Roekaerts, PM | 1 |
| Kanaya, N; Kawana, S; Kimura, H; Matsumoto, M; Miyamoto, A; Namiki, A; Ohshika, H; Tsuchida, H | 1 |
| Dinc, M; Dunn, SM; Oz, M; Tchugunova, Y | 1 |
13 other study(ies) available for halothane and isradipine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Depression of calcium channel blocker binding to rat brain membranes by halothane.
Topics: Animals; Brain; Calcium Channel Blockers; Calcium Channels; Cell Membrane; Dihydropyridines; Enflurane; Halothane; Isoflurane; Isradipine; Male; Rats; Rats, Inbred Strains | 1992 |
Evidence for an interaction of halothane with the L-type Ca2+ channel in human myocardium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Binding Sites; Calcium Channels; Drug Interactions; Female; Halothane; Heart; Humans; Isradipine; Male; Middle Aged; Myocardial Contraction; Myocardium | 1993 |
The role of L-type voltage-dependent calcium channels in anesthetic depression of contractility.
Topics: Anesthetics; Animals; Calcium Channels; Depression, Chemical; Enflurane; Halothane; In Vitro Techniques; Isoflurane; Isradipine; Myocardial Contraction; Rabbits; Rats | 1994 |
Effect of halothane on sarcolemmal calcium channels during myocardial ischemia and reperfusion.
Topics: Animals; Calcium Channels; Dogs; Halothane; Isradipine; Myocardial Ischemia; Myocardial Reperfusion; Sarcolemma | 1994 |
The effects of halothane on voltage-dependent calcium channels in isolated Langendorff-perfused rat heart.
Topics: Animals; Calcium Channels; Female; Halothane; Heart; Isradipine; Male; Myocardial Contraction; Perfusion; Rats; Rats, Sprague-Dawley | 1994 |
Halothane modifies ischemia-associated injury to the voltage-sensitive calcium channels in canine heart sarcolemma.
Topics: Animals; Binding Sites; Calcium Channels; Dogs; Electrophysiology; Halothane; Isradipine; Kinetics; Membranes; Myocardial Ischemia; Myocardial Reperfusion; Radioligand Assay; Sarcolemma; Tritium | 1994 |
Volatile anesthetics inhibit dihydropyridine binding to malignant hyperthermia-susceptible and normal pig skeletal muscle membranes.
Topics: Anesthetics; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Dihydropyridines; Drug Interactions; Halothane; Isradipine; Malignant Hyperthermia; Membranes; Muscle Proteins; Muscles; Swine; Tritium | 1994 |
Alleviation of the peripheral hemodynamic effects of dexmedetomidine by the calcium channel blocker isradipine.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Anesthesia; Anesthetics, Inhalation; Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Catecholamines; Coronary Circulation; Dogs; Halothane; Heart Rate; Hemodynamics; Imidazoles; Isradipine; Medetomidine; Vasodilator Agents | 1997 |
Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Anesthetics, Inhalation; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Halothane; Heart Ventricles; Isradipine; Myocardial Contraction; Myocardium; Nifedipine; Rats; Rats, Wistar; Sarcolemma; Verapamil | 1998 |
Comparison of the effects of xenon and halothane on voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes.
Topics: Anesthetics, Inhalation; Animals; Calcium; Calcium Channels; Halothane; In Vitro Techniques; Intracellular Membranes; Ion Channel Gating; Isradipine; Muscle, Skeletal; Rabbits; Radioligand Assay; Xenon | 2002 |